Please login to the form below

Not currently logged in
Email:
Password:

biotech funding

This page shows the latest biotech funding news and features for those working in and with pharma, biotech and healthcare.

Novavax gets $1.6bn from US government for coronavirus vaccine

Novavax gets $1.6bn from US government for coronavirus vaccine

Latest company to join Operation Warp Speed. The US government has committed a massive $1.6bn in funding to late-stage biotech company Novavax for the accelerated development of its investigational ... So far, that funding has gone to six companies,

Latest news

More from news
Approximately 1 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    Beside problems with funding and management models, one of European biotech’s problems so far has been that companies have been bought out early – illustrated last year by the $4.8bn ... However 2019 has seen some promising signs on this front.

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    Venture capital funds based in China invested $1.4bn into private US biotech firms in the first three months of 2018, accounting for about 40% of the $3.7bn raised in ... In terms of biotech funding, the emergence of Hong Kong’s stock market could

  • Pharma deals in March 2015 Pharma deals in March 2015

    One of Bavarian Nordic's sites is in Martinsried, the biotech cluster near Munich. ... The Morphosys story highlights the uncertainty of funding for European biotech companies.

  • Small diseases need big picture communications Small diseases need big picture communications

    Small pharma or biotech may struggle with funding for communications early on in the development process, while larger pharma may be held back by slow processes that are embedded in a ... May need to travel long distances for care. Difficulties in

  • Interview: Steve Bates, BIA Interview: Steve Bates, BIA

    The CEO of the BioIndustry Association discusses the state of UK biotech, its shared ecosystem with pharma and the funding challenges biotech faces. ... And that's really why getting the investment right for UK biotech is increasingly important.”.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Biotech Innovation in the Time of COVID-19

    Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI &machine learning, and much more!

  • Newcells Biotech secures over £5m for 3D tissue models

    Newcastle-based human stem cell model specialists, Newcells Biotech, have secured a total of £5.25m worth of funding to accelerate their growth plans in the international life sciences market. ... This funding round will help Newcells Biotech expand

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....